318
Participants
Start Date
March 31, 2006
Primary Completion Date
April 30, 2008
Study Completion Date
June 30, 2008
carvedilol controlled release
Carvedilol controlled release (10, 20, 40 or 80 mg) and placebo taken in the morning. Two placebos taken in the evening. A total of 4 pills will be taken PO daily.
carvedilol immediate release
Carvedilol immediate release (3.125, 6.25, 12.5 or 25 mg) and placebo, taken PO, twice-daily.
New York Cardiovascular Associates, New York
Montefiore Medical Center, The Bronx
Long Island Heart Associates, Mineola
South Bay Cardiovascular Associates, West Islip
Albany Associates in Cardiology, Albany
Buffalo Heart Group, LLP, Buffalo
Tri-State Medical Group, Beaver
Blair Medical Associates, Altoona
Mid State Medical Service, Philipsburg
Central Bucks Specialists, Doylestown
Buxmont Cardiology Associates, PC, Sellersville
Cardiology Consultants of Philadelphia, Philadelphia
One Heart, LLC, Baltimore
Winchester Medical Center, Winchester
Wake Forest University Baptist Medical Center, Winston-Salem
LeBauer Cardiovascular Research Foundation, Greensboro
University of North Carolina, Chapel Hill
South Carolina Heart Center, Columbia
Charleston Cardiology, Charleston
Harbin Clinic, Rome
Cardiac Disease Specialists, PC, Atlanta
White-Wilson Medical Center, PA, Fort Walton Beach
Palm Beach Cardiology, Palm Beach Gardens
Bay Area Cardiology, Brandon
Clearwater Cardiovascular and Interventional Consultants, Clearwater
Cardiology Associates, Mobile
Mobile Heart Specialists, Mobile
Cardiology Associates Research, LLC, Tupelo
Cardiovascular Associates, Louisville
Louisville Cardiology Medical Group, Louisville
Comprehensive Cardiology Associates, Florence
Northwest Ohio Cardiology Consultants, Toledo
Sterling Research Group Ltd., Cincinnati
The Lindner Clinical Trial Center, Cincinnati
The Care Group LLC, Indianapolis
River Cities Cardiology, Jeffersonville
Iowa Heart Center, West Des Moines
Green Bay HeartCare, Green Bay
Luther Midelfort Mayo Health Systems, Eau Claire
Regions Hospital Cardiology Research, Saint Paul
St. Paul Cardiology, Saint Paul
Hennepin County Medical Center, Minneapolis
Minnesota Heart Clinic, Edina
Rocky Mountain Heart & Lung, Kalispell
North Shore Cardiovascular Research Consortium, Bannockburn
Saint Francis Hospital, Evanston
Illinois Heart and Vascular, Hinsdale
Rockford Cardiology Research Foundation, Rockford
HeartCare Midwest, Peoria
Prairie Cardiovascular Consultants, Springfield
Mid-America Cardiology, Kansas City
Via Christi Research, Inc., Wichita
Oklahoma Cardiovascular Research Group, Oklahoma City
Heart Specialists, Friendswood
Texas Cardiac Center, Lubbock
Aurora Denver Cardiology Associates, Denver
Medical Center of the Rockies Foundation, Loveland
Intermountain Medical Center, Murray
Heart Center, Salt Lake City
Mayo Clinic Arizona, Phoenix
Scottsdale Cardiovascular Research Institute, Scottsdale
South West Heart, Tucson
Rancho Los Amigos USC, Downey
Medvin Clinical Research, Van Nuys
Southern California Cardiology Medical Group, Inc., San Diego
Inland Heart Doctors Medical Group, Corona
Merced Heart Associates, Merced
William Bowden, DO Private Practice, Healdsburg
Sutter Memorial Hospital, Sacramento
Samaritan Cardiology, Corvallis
South Florida International Cardiology Consultants, Inc., Miami
Diagnostic and Clinical Cardiology, West Orange
University of New Mexico, Albuquerque
University Hospital, Cincinnati
Rhode Island Heart Failure Center, Providence
Collaborators (2)
CTI Clinical Trial and Consulting Services
OTHER
GlaxoSmithKline
INDUSTRY
CTI-1, LLC
INDUSTRY